Exicure, Inc. (Nasdaq: XCUR) today shared updates on its lead asset, GPC-100 (burixafor), a small molecule CXCR4 inhibitor. Exicure, Inc. ("Exicure") is planning for a clinical trial in Acute Myeloid ...

A multi-institutional team developed a chimeric antigen receptor (CAR) T cell-based strategy for specifically targeting AML cells in patients who relapsed following other treatments. The team ...

Omeros forms oncology committee to guide development of its AML therapy, which showed strong efficacy and safety in ...

A Winnipeg couple has temporarily relocated to Memphis, Tennessee, in search of lifesaving treatment for their 3-year-old son ...

A seven-year-old boy holds a sign with four words that his family and the community have been waiting to hear: “I am cancer ...

A Chatham grandmother has been making trips from Savannah to St. Jude Children’s Research Hospital in Memphis for two years ...

Apple Watch has time and again helped people get health alert and making them rush to the doctor before something tragic ...

Nancy Jalowiecki was holding mementos from her late husband - photos and his guitar pick - at a bereavement camp when her ...

Ex on the Beach star Ashley Cain defends his mystery partner from vile trolls after the birth of their third child, and ...

We recently published a list of Billionaire Stanley Druckenmiller’s Top 10 Stocks Picks with Huge Upside Potential. In this ...

Rhees Goodridge, 36, went to the ER last month with an infected abcess that only required a small surgery. Then the doctors ...